Partners Group to acquire Pharmathen from BC Partners
Global private markets firm Partners Group has, on behalf of its clients, agreed to acquire Pharmathen, a European pharmaceutical company, from international investment firm BC Partners. The transaction values the Company at an enterprise value of around EUR1.6 billion. Founded in 1969, Pharmathen is a contract development and manufacturing organisation
